WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More People Died of Antibiotic-Resistant ‘Superbugs’ than HIV/AIDS in 2019; Sub-Saharan Africa Worst Affected 20/01/2022 Aishwarya Tendolkar Antibiotic-resistant bacterial infections killed 1.27 million people in the world in 2019, according to a one-of-a-kind study in The Lancet. According to the study, led by the Institute of Health Metrics and Evaluation (IHME) at the University of Washington, with dozens of authors worldwide, the increased resistance of many common pathogens to treatment, known as […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers 14/01/2022 Maayan Hoffman Two new treatments for COVID-19 were recommended on Thursday by the World Health Organization’s Guideline Development Group of international experts – one for severely ill patients and the other for those patients who are not severely ill but most likely to develop severe disease. The recommendations were announced Friday morning in the BMJ. Both drugs, […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gloomy New Year Prognosis – WHO Experts Warn Omicron Could Also Spawn More Dangerous Variants 06/01/2022 Maayan Hoffman Mass Omicron infection could lead to the formation of new and potentially even more dangerous coronavirus variants, officials from the World Health Organization warned on Thursday. That is despite the fact that the Omicron variant is proving less lethal than its SARS-CoV2 predecessors, such as Alpha, Beta and Delta – which swept through India and […] Continue reading -> Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Second J& J Jab Provides 85% Protection Against Omicron Hospitalization in New South African Study 30/12/2021 Elaine Ruth Fletcher A new South African study shows that a second Johnson & Johnson dose, administered 6-9 months after the initial single-dose vaccine provided 84% protection against hospitalization from the Omicron SARS-CoV2 variant – results that even outperformed those of an earlier South African study looking at effectiveness of the two-dose Pfizer regime in the face of […] Continue reading -> Posts navigation Older postsNewer posts